 | • レポートコード：QAF27828 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のPEG化タンパク質市場について種類別（コロニー刺激因子、インターフェロン、エリスロポエチン（EPO）、組換え第VIII因子、モノクローナル抗体、その他）、用途別（がん治療、肝炎、慢性腎臓病、白血病、SCID、関節リウマチ、クローン病、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・PEG化タンパク質市場の概要 ・世界の主要地域別PEG化タンパク質市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のPEG化タンパク質市場規模2016-2021：種類別（コロニー刺激因子、インターフェロン、エリスロポエチン（EPO）、組換え第VIII因子、モノクローナル抗体、その他） ・世界のPEG化タンパク質市場予測2012-2027：種類別（コロニー刺激因子、インターフェロン、エリスロポエチン（EPO）、組換え第VIII因子、モノクローナル抗体、その他） ・世界のPEG化タンパク質市場規模2016-2021：用途別（がん治療、肝炎、慢性腎臓病、白血病、SCID、関節リウマチ、クローン病、その他） ・世界のPEG化タンパク質市場予測2012-2027：用途別（がん治療、肝炎、慢性腎臓病、白血病、SCID、関節リウマチ、クローン病、その他） ・PEG化タンパク質のアメリカ市場規模と予測2016-2021 ・PEG化タンパク質のヨーロッパ市場規模と予測2016-2021 ・PEG化タンパク質の中国市場規模と予測2016-2021 ・PEG化タンパク質の日本市場規模と予測2016-2021 ・PEG化タンパク質の東南アジア市場規模と予測2016-2021 ・PEG化タンパク質のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （ENZON Pharmaceuticals、Merck Sharp & Dohme、Roche、Pfizer、Amgen、UCB、Crealta (Savient)） ・PEG化タンパク質の製造コスト分析 ・販売チャネル、流通業者、顧客 ・PEG化タンパク質の市場動向・機会・課題 ・調査の結論 |
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturers and suppliers lose their bargaining power. Consumers are able to purchase competitor’s products if they are not satisfied with product price or quality. In order for suppliers to tackle the challenge of threat of substitutes, they have to innovate products which meet the needs of their target market segments.
Market Analysis and Insights: Global PEGylated Proteins Market
The global PEGylated Proteins market was valued at US$ 3769 in 2020 and will reach US$ 4714.2 million by the end of 2027, growing at a CAGR of 3.8% during 2022-2027.
Global PEGylated Proteins Scope and Market Size
The global PEGylated Proteins market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global PEGylated Proteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibodies
Others
Segment by Application
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn’s Disease
Others
The PEGylated Proteins market is analysed and market size information is provided by regions (countries). Segment by Application, the PEGylated Proteins market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
1 PEGylated Proteins Market Overview
1.1 PEGylated Proteins Product Scope
1.2 PEGylated Proteins Segment by Type
1.2.1 Global PEGylated Proteins Sales by Type (2016 & 2021 & 2027)
1.2.2 Colony Stimulating Factors
1.2.3 Interferons
1.2.4 Erythropoietin (EPO)
1.2.5 Recombinant Factor VIII
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 PEGylated Proteins Segment by Application
1.3.1 Global PEGylated Proteins Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Cancer Treatment
1.3.3 Hepatitis
1.3.4 Chronic Kidney Disease
1.3.5 Leukemia
1.3.6 SCID
1.3.7 Rheumatoid Arthritis & Crohn’s Disease
1.3.8 Others
1.4 PEGylated Proteins Market Estimates and Forecasts (2016-2027)
1.4.1 Global PEGylated Proteins Market Size in Value Growth Rate (2016-2027)
1.4.2 Global PEGylated Proteins Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global PEGylated Proteins Price Trends (2016-2027)
2 PEGylated Proteins Estimates and Forecasts by Region
2.1 Global PEGylated Proteins Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global PEGylated Proteins Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global PEGylated Proteins Sales Market Share by Region (2016-2021)
2.2.2 Global PEGylated Proteins Revenue Market Share by Region (2016-2021)
2.3 Global PEGylated Proteins Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global PEGylated Proteins Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global PEGylated Proteins Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America PEGylated Proteins Estimates and Projections (2016-2027)
2.4.2 Europe PEGylated Proteins Estimates and Projections (2016-2027)
2.4.3 China PEGylated Proteins Estimates and Projections (2016-2027)
2.4.4 Japan PEGylated Proteins Estimates and Projections (2016-2027)
2.4.5 Southeast Asia PEGylated Proteins Estimates and Projections (2016-2027)
2.4.6 India PEGylated Proteins Estimates and Projections (2016-2027)
3 Global PEGylated Proteins Competition Landscape by Players
3.1 Global Top PEGylated Proteins Players by Sales (2016-2021)
3.2 Global Top PEGylated Proteins Players by Revenue (2016-2021)
3.3 Global PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PEGylated Proteins as of 2020)
3.4 Global PEGylated Proteins Average Price by Company (2016-2021)
3.5 Manufacturers PEGylated Proteins Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global PEGylated Proteins Market Size by Type
4.1 Global PEGylated Proteins Historic Market Review by Type (2016-2021)
4.1.1 Global PEGylated Proteins Sales Market Share by Type (2016-2021)
4.1.2 Global PEGylated Proteins Revenue Market Share by Type (2016-2021)
4.1.3 Global PEGylated Proteins Price by Type (2016-2021)
4.2 Global PEGylated Proteins Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global PEGylated Proteins Sales Forecast by Type (2022-2027)
4.2.2 Global PEGylated Proteins Revenue Forecast by Type (2022-2027)
4.2.3 Global PEGylated Proteins Price Forecast by Type (2022-2027)
5 Global PEGylated Proteins Market Size by Application
5.1 Global PEGylated Proteins Historic Market Review by Application (2016-2021)
5.1.1 Global PEGylated Proteins Sales Market Share by Application (2016-2021)
5.1.2 Global PEGylated Proteins Revenue Market Share by Application (2016-2021)
5.1.3 Global PEGylated Proteins Price by Application (2016-2021)
5.2 Global PEGylated Proteins Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global PEGylated Proteins Sales Forecast by Application (2022-2027)
5.2.2 Global PEGylated Proteins Revenue Forecast by Application (2022-2027)
5.2.3 Global PEGylated Proteins Price Forecast by Application (2022-2027)
6 North America PEGylated Proteins Market Facts & Figures
6.1 North America PEGylated Proteins Sales by Company
6.1.1 North America PEGylated Proteins Sales by Company (2016-2021)
6.1.2 North America PEGylated Proteins Revenue by Company (2016-2021)
6.2 North America PEGylated Proteins Sales Breakdown by Type
6.2.1 North America PEGylated Proteins Sales Breakdown by Type (2016-2021)
6.2.2 North America PEGylated Proteins Sales Breakdown by Type (2022-2027)
6.3 North America PEGylated Proteins Sales Breakdown by Application
6.3.1 North America PEGylated Proteins Sales Breakdown by Application (2016-2021)
6.3.2 North America PEGylated Proteins Sales Breakdown by Application (2022-2027)
7 Europe PEGylated Proteins Market Facts & Figures
7.1 Europe PEGylated Proteins Sales by Company
7.1.1 Europe PEGylated Proteins Sales by Company (2016-2021)
7.1.2 Europe PEGylated Proteins Revenue by Company (2016-2021)
7.2 Europe PEGylated Proteins Sales Breakdown by Type
7.2.1 Europe PEGylated Proteins Sales Breakdown by Type (2016-2021)
7.2.2 Europe PEGylated Proteins Sales Breakdown by Type (2022-2027)
7.3 Europe PEGylated Proteins Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China PEGylated Proteins Market Facts & Figures
8.1 China PEGylated Proteins Sales by Company
8.1.1 China PEGylated Proteins Sales by Company (2016-2021)
8.1.2 China PEGylated Proteins Revenue by Company (2016-2021)
8.2 China PEGylated Proteins Sales Breakdown by Type
8.2.1 China PEGylated Proteins Sales Breakdown by Type (2016-2021)
8.2.2 China PEGylated Proteins Sales Breakdown by Type (2022-2027)
8.3 China PEGylated Proteins Sales Breakdown by Application
8.3.1 China 241 Sales Breakdown by Application (2016-2021)
8.3.2 China 241 Sales Breakdown by Application (2022-2027)
9 Japan PEGylated Proteins Market Facts & Figures
9.1 Japan PEGylated Proteins Sales by Company
9.1.1 Japan PEGylated Proteins Sales by Company (2016-2021)
9.1.2 Japan PEGylated Proteins Revenue by Company (2016-2021)
9.2 Japan PEGylated Proteins Sales Breakdown by Type
9.2.1 Japan PEGylated Proteins Sales Breakdown by Type (2016-2021)
9.2.2 Japan PEGylated Proteins Sales Breakdown by Type (2022-2027)
9.3 Japan PEGylated Proteins Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia PEGylated Proteins Market Facts & Figures
10.1 Southeast Asia PEGylated Proteins Sales by Company
10.1.1 Southeast Asia PEGylated Proteins Sales by Company (2016-2021)
10.1.2 Southeast Asia PEGylated Proteins Revenue by Company (2016-2021)
10.2 Southeast Asia PEGylated Proteins Sales Breakdown by Type
10.2.1 Southeast Asia PEGylated Proteins Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia PEGylated Proteins Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia PEGylated Proteins Sales Breakdown by Application
10.3.1 Southeast Asia g Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia g Sales Breakdown by Application (2022-2027)
11 India PEGylated Proteins Market Facts & Figures
11.1 India PEGylated Proteins Sales by Company
11.1.1 India PEGylated Proteins Sales by Company (2016-2021)
11.1.2 India PEGylated Proteins Revenue by Company (2016-2021)
11.2 India PEGylated Proteins Sales Breakdown by Type
11.2.1 India PEGylated Proteins Sales Breakdown by Type (2016-2021)
11.2.2 India PEGylated Proteins Sales Breakdown by Type (2022-2027)
11.3 India PEGylated Proteins Sales Breakdown by Application
11.3.1 India PEGylated Proteins Sales Breakdown by Application (2016-2021)
11.3.2 India PEGylated Proteins Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in PEGylated Proteins Business
12.1 ENZON Pharmaceuticals
12.1.1 ENZON Pharmaceuticals Corporation Information
12.1.2 ENZON Pharmaceuticals Business Overview
12.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
12.1.4 ENZON Pharmaceuticals PEGylated Proteins Products Offered
12.1.5 ENZON Pharmaceuticals Recent Development
12.2 Merck Sharp & Dohme
12.2.1 Merck Sharp & Dohme Corporation Information
12.2.2 Merck Sharp & Dohme Business Overview
12.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Sharp & Dohme PEGylated Proteins Products Offered
12.2.5 Merck Sharp & Dohme Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Business Overview
12.3.3 Roche PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche PEGylated Proteins Products Offered
12.3.5 Roche Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer PEGylated Proteins Products Offered
12.4.5 Pfizer Recent Development
12.5 Amgen
12.5.1 Amgen Corporation Information
12.5.2 Amgen Business Overview
12.5.3 Amgen PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amgen PEGylated Proteins Products Offered
12.5.5 Amgen Recent Development
12.6 UCB
12.6.1 UCB Corporation Information
12.6.2 UCB Business Overview
12.6.3 UCB PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
12.6.4 UCB PEGylated Proteins Products Offered
12.6.5 UCB Recent Development
12.7 Crealta (Savient)
12.7.1 Crealta (Savient) Corporation Information
12.7.2 Crealta (Savient) Business Overview
12.7.3 Crealta (Savient) PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Crealta (Savient) PEGylated Proteins Products Offered
12.7.5 Crealta (Savient) Recent Development
…
13 PEGylated Proteins Manufacturing Cost Analysis
13.1 PEGylated Proteins Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of PEGylated Proteins
13.4 PEGylated Proteins Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 PEGylated Proteins Distributors List
14.3 PEGylated Proteins Customers
15 Market Dynamics
15.1 PEGylated Proteins Market Trends
15.2 PEGylated Proteins Drivers
15.3 PEGylated Proteins Market Challenges
15.4 PEGylated Proteins Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global PEGylated Proteins Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global PEGylated Proteins Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global PEGylated Proteins Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global PEGylated Proteins Sales (g) by Region (2016-2021)
Table 5. Global PEGylated Proteins Sales Market Share by Region (2016-2021)
Table 6. Global PEGylated Proteins Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global PEGylated Proteins Revenue Share by Region (2016-2021)
Table 8. Global PEGylated Proteins Sales (g) Forecast by Region (2022-2027)
Table 9. Global PEGylated Proteins Sales Market Share Forecast by Region (2022-2027)
Table 10. Global PEGylated Proteins Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global PEGylated Proteins Revenue Share Forecast by Region (2022-2027)
Table 12. Global PEGylated Proteins Sales (g) of Key Companies (2016-2021)
Table 13. Global PEGylated Proteins Sales Share by Company (2016-2021)
Table 14. Global PEGylated Proteins Revenue (US$ Million) by Company (2016-2021)
Table 15. Global PEGylated Proteins Revenue Share by Company (2016-2021)
Table 16. Global PEGylated Proteins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PEGylated Proteins as of 2020)
Table 17. Global PEGylated Proteins Average Price (USD/mg) of Key Company (2016-2021)
Table 18. Manufacturers PEGylated Proteins Manufacturing Sites and Area Served
Table 19. Manufacturers PEGylated Proteins Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global PEGylated Proteins Sales (g) by Type (2016-2021)
Table 22. Global PEGylated Proteins Sales Share by Type (2016-2021)
Table 23. Global PEGylated Proteins Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global PEGylated Proteins Price (USD/mg) by Type (2016-2021)
Table 25. Global PEGylated Proteins Sales Share by Type (2022-2027)
Table 26. Global PEGylated Proteins Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global PEGylated Proteins Revenue Share by Type (2022-2027)
Table 28. Global PEGylated Proteins Price (USD/mg) by Type (2022-2027)
Table 29. Global PEGylated Proteins Sales (g) by Application (2016-2021)
Table 30. Global PEGylated Proteins Sales Share by Application (2016-2021)
Table 31. Global PEGylated Proteins Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global PEGylated Proteins Price (USD/mg) by Application (2016-2021)
Table 33. Global PEGylated Proteins Sales (g) by Application (2022-2027)
Table 34. Global PEGylated Proteins Sales Share by Application (2022-2027)
Table 35. Global PEGylated Proteins Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global PEGylated Proteins Revenue Share by Application (2022-2027)
Table 37. Global PEGylated Proteins Price (USD/mg) by Application (2022-2027)
Table 38. North America PEGylated Proteins Sales (g) by Company (2016-2021)
Table 39. North America PEGylated Proteins Sales Market Share by Company (2016-2021)
Table 40. North America PEGylated Proteins Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America PEGylated Proteins Revenue Market Share by Company (2016-2021)
Table 42. North America PEGylated Proteins Sales by Type (2016-2021) & (g)
Table 43. North America PEGylated Proteins Sales Market Share by Type (2016-2021)
Table 44. North America PEGylated Proteins Sales by Type (2022-2027) & (g)
Table 45. North America PEGylated Proteins Sales Market Share by Type (2022-2027)
Table 46. North America PEGylated Proteins Sales by Application (2016-2021) & (g)
Table 47. North America PEGylated Proteins Sales Market Share by Application (2016-2021)
Table 48. North America PEGylated Proteins Sales by Application (2022-2027) & (g)
Table 49. North America PEGylated Proteins Sales Market Share by Application (2022-2027)
Table 50. Europe PEGylated Proteins Sales (g) by Company (2016-2021)
Table 51. Europe PEGylated Proteins Sales Market Share by Company (2016-2021)
Table 52. Europe PEGylated Proteins Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe PEGylated Proteins Revenue Market Share by Company (2016-2021)
Table 54. Europe PEGylated Proteins Sales by Type (2016-2021) & (g)
Table 55. Europe PEGylated Proteins Sales Market Share by Type (2016-2021)
Table 56. Europe PEGylated Proteins Sales by Type (2022-2027) & (g)
Table 57. Europe PEGylated Proteins Sales Market Share by Type (2022-2027)
Table 58. Europe PEGylated Proteins Sales by Application (2016-2021) & (g)
Table 59. Europe PEGylated Proteins Sales Market Share by Application (2016-2021)
Table 60. Europe PEGylated Proteins Sales by Application (2022-2027) & (g)
Table 61. Europe PEGylated Proteins Sales Market Share by Application (2022-2027)
Table 62. China PEGylated Proteins Sales (g) by Company (2016-2021)
Table 63. China PEGylated Proteins Sales Market Share by Company (2016-2021)
Table 64. China PEGylated Proteins Revenue by Company (2016-2021) & (US$ Million)
Table 65. China PEGylated Proteins Revenue Market Share by Company (2016-2021)
Table 66. China PEGylated Proteins Sales by Type (2016-2021) & (g)
Table 67. China PEGylated Proteins Sales Market Share by Type (2016-2021)
Table 68. China PEGylated Proteins Sales by Type (2022-2027) & (g)
Table 69. China PEGylated Proteins Sales Market Share by Type (2022-2027)
Table 70. China PEGylated Proteins Sales by Application (2016-2021) & (g)
Table 71. China PEGylated Proteins Sales Market Share by Application (2016-2021)
Table 72. China PEGylated Proteins Sales by Application (2022-2027) & (g)
Table 73. China PEGylated Proteins Sales Market Share by Application (2022-2027)
Table 74. Japan PEGylated Proteins Sales (g) by Company (2016-2021)
Table 75. Japan PEGylated Proteins Sales Market Share by Company (2016-2021)
Table 76. Japan PEGylated Proteins Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan PEGylated Proteins Revenue Market Share by Company (2016-2021)
Table 78. Japan PEGylated Proteins Sales by Type (2016-2021) & (g)
Table 79. Japan PEGylated Proteins Sales Market Share by Type (2016-2021)
Table 80. Japan PEGylated Proteins Sales by Type (2022-2027) & (g)
Table 81. Japan PEGylated Proteins Sales Market Share by Type (2022-2027)
Table 82. Japan PEGylated Proteins Sales by Application (2016-2021) & (g)
Table 83. Japan PEGylated Proteins Sales Market Share by Application (2016-2021)
Table 84. Japan PEGylated Proteins Sales by Application (2022-2027) & (g)
Table 85. Japan PEGylated Proteins Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia PEGylated Proteins Sales (g) by Company (2016-2021)
Table 87. Southeast Asia PEGylated Proteins Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia PEGylated Proteins Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia PEGylated Proteins Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia PEGylated Proteins Sales by Type (2016-2021) & (g)
Table 91. Southeast Asia PEGylated Proteins Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia PEGylated Proteins Sales by Type (2022-2027) & (g)
Table 93. Southeast Asia PEGylated Proteins Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia PEGylated Proteins Sales by Application (2016-2021) & (g)
Table 95. Southeast Asia PEGylated Proteins Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia PEGylated Proteins Sales by Application (2022-2027) & (g)
Table 97. Southeast Asia PEGylated Proteins Sales Market Share by Application (2022-2027)
Table 98. India PEGylated Proteins Sales (g) by Company (2016-2021)
Table 99. India PEGylated Proteins Sales Market Share by Company (2016-2021)
Table 100. India PEGylated Proteins Revenue by Company (2016-2021) & (US$ Million)
Table 101. India PEGylated Proteins Revenue Market Share by Company (2016-2021)
Table 102. India PEGylated Proteins Sales by Type (2016-2021) & (g)
Table 103. India PEGylated Proteins Sales Market Share by Type (2016-2021)
Table 104. India PEGylated Proteins Sales by Type (2022-2027) & (g)
Table 105. India PEGylated Proteins Sales Market Share by Type (2022-2027)
Table 106. India PEGylated Proteins Sales by Application (2016-2021) & (g)
Table 107. India PEGylated Proteins Sales Market Share by Application (2016-2021)
Table 108. India PEGylated Proteins Sales by Application (2022-2027) & (g)
Table 109. India PEGylated Proteins Sales Market Share by Application (2022-2027)
Table 110. ENZON Pharmaceuticals Corporation Information
Table 111. ENZON Pharmaceuticals Description and Business Overview
Table 112. ENZON Pharmaceuticals PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 113. ENZON Pharmaceuticals PEGylated Proteins Product
Table 114. ENZON Pharmaceuticals Recent Development
Table 115. Merck Sharp & Dohme Corporation Information
Table 116. Merck Sharp & Dohme Description and Business Overview
Table 117. Merck Sharp & Dohme PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 118. Merck Sharp & Dohme PEGylated Proteins Product
Table 119. Merck Sharp & Dohme Recent Development
Table 120. Roche Corporation Information
Table 121. Roche Description and Business Overview
Table 122. Roche PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 123. Roche PEGylated Proteins Product
Table 124. Roche Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 128. Pfizer PEGylated Proteins Product
Table 129. Pfizer Recent Development
Table 130. Amgen Corporation Information
Table 131. Amgen Description and Business Overview
Table 132. Amgen PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 133. Amgen PEGylated Proteins Product
Table 134. Amgen Recent Development
Table 135. UCB Corporation Information
Table 136. UCB Description and Business Overview
Table 137. UCB PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 138. UCB PEGylated Proteins Product
Table 139. UCB Recent Development
Table 140. Crealta (Savient) Corporation Information
Table 141. Crealta (Savient) Description and Business Overview
Table 142. Crealta (Savient) PEGylated Proteins Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 143. Crealta (Savient) PEGylated Proteins Product
Table 144. Crealta (Savient) Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. PEGylated Proteins Distributors List
Table 148. PEGylated Proteins Customers List
Table 149. PEGylated Proteins Market Trends
Table 150. PEGylated Proteins Market Drivers
Table 151. PEGylated Proteins Market Challenges
Table 152. PEGylated Proteins Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. PEGylated Proteins Product Picture
Figure 2. Global PEGylated Proteins Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global PEGylated Proteins Sales Market Share by Application in 2021 & 2027
Figure 6. Cancer Treatment Examples
Figure 7. Hepatitis Examples
Figure 8. Chronic Kidney Disease Examples
Figure 9. Leukemia Examples
Figure 10. SCID Examples
Figure 11. Rheumatoid Arthritis & Crohn's Disease Examples
Figure 12. Others Examples
Figure 13. Global PEGylated Proteins Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global PEGylated Proteins Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global PEGylated Proteins Sales (g) Growth Rate (2016-2027)
Figure 16. Global PEGylated Proteins Price Trends Growth Rate (2016-2027) (USD/mg)
Figure 17. Global PEGylated Proteins Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global PEGylated Proteins Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America PEGylated Proteins Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America PEGylated Proteins Sales (g) Growth Rate (2016-2027)
Figure 21. Europe PEGylated Proteins Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe PEGylated Proteins Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China PEGylated Proteins Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China PEGylated Proteins Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan PEGylated Proteins Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan PEGylated Proteins Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia PEGylated Proteins Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia PEGylated Proteins Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India PEGylated Proteins Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India PEGylated Proteins Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest PEGylated Proteins Players Market Share by Revenue in PEGylated Proteins: 2016 & 2020
Figure 32. PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global PEGylated Proteins Revenue Share by Type (2016-2021)
Figure 34. Global PEGylated Proteins Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global PEGylated Proteins Revenue Share by Application (2016-2021)
Figure 36. Global PEGylated Proteins Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America PEGylated Proteins Sales Market Share by Type in 2020
Figure 38. North America PEGylated Proteins Sales Market Share by Application in 2020
Figure 39. Europe PEGylated Proteins Sales Market Share by Type in 2020
Figure 40. Europe PEGylated Proteins Sales Market Share by Application in 2020
Figure 41. China PEGylated Proteins Sales Market Share by Type in 2020
Figure 42. China PEGylated Proteins Sales Market Share by Application in 2020
Figure 43. Japan PEGylated Proteins Sales Market Share by Type in 2020
Figure 44. Japan PEGylated Proteins Sales Market Share by Application in 2020
Figure 45. Southeast Asia PEGylated Proteins Sales Market Share by Type in 2020
Figure 46. Southeast Asia PEGylated Proteins Sales Market Share by Application in 2020
Figure 47. India PEGylated Proteins Sales Market Share by Type in 2020
Figure 48. India PEGylated Proteins Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of PEGylated Proteins
Figure 51. Manufacturing Process Analysis of PEGylated Proteins
Figure 52. PEGylated Proteins Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
世界のタンパク質＆抗体＆核酸デリバリー技術市場規模・現状・予測（2021年-2027年） Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Given their high target specificity and limited toxicity compared to small molecule drugs, biotherapeutics have revolutionized treatment paradigms in a myriad of clinical conditions, including metabolic disorders, cancer, neur…- 世界の組換え血漿タンパク質市場規模・現状・予測（2021年-2027年） For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins--such as coagulation factors, anticoagulants, immunoglobulins, and albumin--essential to the treatment of serious congenital or acquired bleeding or immunological diseases…
- 不凍タンパク質（AFP）のグローバル市場2021 Market Analysis and Insights: Global Antifreeze Proteins (AFP) Market The global Antifreeze Proteins (AFP) market was valued at US$ 12 in 2020 and will reach US$ 16 million by the end of 2027, growing at a CAGR of 5.0% during 2022-2027. Global Antifreeze Proteins (AFP) Scope and Market Size The glob…
- 精製ヒトタンパク質のグローバル市場2021 Purified Human Proteins applied in Native antigens for optimized antibody production, Positive controls in ELISA and other antibody assays, Protein-protein interaction, in vitro biochemical assays and cell-based functional assays, Heavy labeled protein as SRM/MRM standards and other in vitro diagnos…
- 世界の治療用タンパク質＆経口ワクチン市場規模・現状・予測（2021年-2027年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There …